Immunotec Inc.

Immunotec Inc.

February 02, 2016 16:05 ET

Immunotec Announces Issuance of Bonus Shares

VAUDREUIL-DORION, QUEBEC--(Marketwired - Feb. 2, 2016) - Immunotec Inc. (TSX VENTURE:IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"), today announced that pursuant to the Immunotec Management Incentive Plan ("MIP"), executives, employees and a consultant ("Eligible Employees") were granted an aggregate of 473,750 Common Shares of Immunotec in partial payment of bonuses ("Bonus Shares") for the 2015 financial year; 255,825 of these Bonus Shares were issued to officers of the Corporation.

Pursuant to the MIP, bonuses were payable in cash (2/3) and in Shares (1/3) to Eligible Employees if certain financial milestones were met by Immunotec. Since such financial milestones were met during the 2015 financial year, the Company today issued Bonus Shares having a value of $151,600, based on the closing price of its Common Shares on the TSX Venture Exchange the trading day preceding their issuance. The full text of the MIP appears in the Company's Management Proxy Circular filed on SEDAR on February 19, 2015 and may be consulted at

About Immunotec Inc.

Immunotec is a Canadian-based Company that develops, manufactures, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the U.S., Mexico, Dominican Republic, United Kingdom and Ireland. The Company offers an extensive family of nutritional, skin care and wellness products targeting health, weight management, as well as energy and performance.

Please visit us at for additional information.

The Company files its continuous disclosure documents inclusive of its year end results on the SEDAR database at and on the Company's website at The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Immunotec Inc.
    Patrick Montpetit CPA:CA, CF
    Vice-President and Chief Financial Officer
    (450) 510-4527